No Data
No Data
Petros Pharmaceuticals To Carry Out 1-for-25 Reverse Stock Split On May 1st, 2025
Petros Pharmaceuticals to Effect 1-for-25 Reverse Stock Split
Petros Pharmaceuticals Approves Key Amendments to Incorporation
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Petros Pharmaceuticals Full Year 2024 Earnings: US$3.34 Loss per Share (Vs US$6.35 Loss in FY 2023)
G3636G : u r our MVP all the times. txs and best regards to your effort to keep us sane and positively
105360556小强 : Thank you.
Entered a short position by mistake yesterday, and today made up a little.